POPULATION-AWARE POLYGENIC RISK ASSESSMENT
From Genetic Diversity to
Predictive Clarity
V-RISK translates polygenic information into clear cardiovascular and metabolic risk insights. Designed for integration into professional healthcare pathways, it supports more informed risk assessment, prevention planning and patient communication.
Developed for laboratories, clinicians and healthcare partners.
01 / V-RISK
A More Complete View of Inherited Risk
Conventional risk assessment focuses primarily on clinical and lifestyle factors. Yet a substantial component of susceptibility to common diseases is distributed across thousands of genetic variants and may remain undetected by conventional genetic testing.
V-RISK uses polygenic risk scores to estimate this cumulative inherited susceptibility. Results are interpreted in population context and presented through structured reports designed to support—not replace—clinical evaluation and established risk assessment tools.
02 / WHY V-RISK
Genetic Risk Made More
Relevant and Actionable
01. Population-Aware Interpretation
Genetic background can influence the performance and interpretation of polygenic risk scores. V-RISK incorporates population context to support more appropriate and transparent risk assessment across diverse individuals.
03. Integrated Risk Context
Genetic susceptibility is considered alongside relevant clinical and lifestyle factors, supporting a broader view of individual risk.
02. Clinically Relevant Reporting
Complex genomic results are translated into structured risk categories, concise explanations and practical points for clinical discussion.
04. Professional Delivery
V-RISK is designed for use through laboratories, clinicians and healthcare organizations rather than as a direct-to-consumer genetic test.
03 / PANEL COVERAGE
Genetic Risk Made More
Relevant and Actionable
V-RISK assesses inherited susceptibility across selected cardiovascular, metabolic and lipid-related phenotype
CARDIOVASCULAR RISK
01—03
METABOLIC AND LIPID RISK
04—08
04 / HOW IT WORKS
From Sample to
Structured Risk Insight
01—03
01
02
03
04
Sample and
Genotyping
A DNA sample is processed using an established SNP genotyping workflow through an authorized laboratory.
Quality Control and Population Context
Genotype data undergo defined quality-control procedures and population-aware analytical assessment.
Polygenic
Risk Analysis
Validated computational workflows calculate risk scores for the phenotypes included in the panel.
Structured Reporting
Results are presented using clear risk categories, supporting explanations and audience-appropriate recommendations for professional review and communication.
05 / REPORTING
Designed for Clearer
Clinical Communication
Polygenic risk is probabilistic rather than deterministic. V-RISK reports are therefore designed to communicate both the potential relevance and the limitations of each result.
A polygenic risk result does not diagnose disease. It provides an additional layer of information that should be interpreted together with clinical findings, family history and established risk factors.
01
Clear risk stratification and Population-aware interpretation
02
Disease-specific result summaries and Individual-facing explanations
03
Clinician-facing interpretation points and elevant clinical and lifestyle context
04
Transparent limitations and multilingual reporting options